May 14, 2020
binx health Announces Publication of Pivotal Study in JAMA Network Open
Apr 30, 2020
binx health Announces Second FDA 510(k) Clearance Of Its Molecular Point-Of-Care Infectious Disease Platform
Jan 13, 2020
Given market demand, binx health announces launch of pre-order program for its first-of-kind rapid, molecular point-of-care platform
Dec 03, 2019
PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora®
Nov 13, 2019
Evofem Biosciences to Participate in Upcoming Investor Conferences
Sep 25, 2019
Evofem Biosciences to Present at Cantor Global Healthcare Conference on October 4, 2019
Aug 22, 2019
Evofem Biosciences to Present at Upcoming Healthcare Conferences
Aug 20, 2019
Orbis Celebrates New Data Showing a 91% Reduction in Populations at Risk of Blinding Trachoma in Endemic Areas
Aug 12, 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Jun 18, 2019
UMN Medical School Report Shows Sexually Transmitted Infections at All-Time High Among MN Youth
Jan 03, 2019
Evofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
Dec 03, 2018
Sightsavers: $105 Million Disease Fund Launched at Star-studded Nelson Mandela Concert
Oct 03, 2018
Evofem Biosciences to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora at the 2018 International Federation of Gynecology and Obstetrics (FIGO) World Congress
Sep 26, 2018
Publication Demonstrates Important Healthcare Benefits of Point-of-Care Testing for Sexually Transmitted Infections
Aug 23, 2018
Evofem Biosciences to Present at 20th Annual Global Investment Conference on September 6, 2018
Aug 02, 2018
Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Jul 03, 2018
Pelvic Exams Do Not Help Diagnose STDs In Adolescent Girls, Study Says
Apr 09, 2018
New Survey: False Beliefs about Sexual Risk, Poor Physician-Patient Communication May Impede STD Screening in Young Women
Jan 23, 2018
Evofem Biosciences Announces First Patient Enrolled in Phase 2b/3 STI Trial of Amphora® and Expects Phase 3 Contraceptive Clinical Trial Data First Quarter 2019
Jun 15, 2017
Chlamydia Infection Diagnostics and Therapeutics Market is Expected to Reach US$2,002.2 Million by 2025